GENinCode Plc (LON:GENI – Get Free Report) was up 13.6% during trading on Thursday . The stock traded as high as GBX 1.25 and last traded at GBX 1.25. Approximately 4,552,396 shares changed hands during trading, an increase of 39% from the average daily volume of 3,274,655 shares. The stock had previously closed at GBX 1.10.
GENinCode Stock Performance
The company has a debt-to-equity ratio of 9.28, a current ratio of 2.60 and a quick ratio of 15.89. The stock has a fifty day simple moving average of GBX 2.27 and a two-hundred day simple moving average of GBX 2.41. The firm has a market capitalization of £3.60 million, a P/E ratio of -0.53 and a beta of 0.66.
About GENinCode
GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.
GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.
See Also
- Five stocks we like better than GENinCode
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
